Poly(ADP-ribosyl)ation, a molecular switch of transcription, shows an attractive relationship with urokinase expression

Thrombosis and Haemostasis

Volumn 93, Issue 2, 2005, Pages 220-227

  Chevanne, Marta ^a   Caldini, Riccardo ^a   Del Rosso, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Endothelial cells; FGF2; Gene expression; PARP; Plasminogen activators

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TANKYRASE; UROKINASE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DNA REPAIR; DNA TRANSCRIPTION; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; GENETIC STABILITY; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; REVIEW; SYSTEMATIC REVIEW; TISSUE INJURY; TRANSCRIPTION REGULATION;

ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 13844267700     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-09-0605     Document Type: Review

References (95)

1. Ziegler M, Oei SL. A cellular survival switch: poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription. BioEssays 2001; 23: 543-48.
2. Althaus FR, Bachmann S, Höfferer L, et al. Interactions of poly(ADP-ribose) with nuclear proteins. Biochimie 1995; 77: 423-32.
3. Chambon P, Weill JD, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 1963; 11: 39-43.
4. D'Amours D, Desnoyers S, D'Silva I, et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999; 342: 249-68.
5. Scovassi AI. Mitochondrial poly(ADP-ribosylation): from old data to new perspectives. EASEB J. 2004; 18: 1-2.
6. Chatterjee S, Berger SJ, Berger NA. Poly(ADP-ribose) polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Mol Cell Biochem 1999; 193: 23-30.
7. Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. BioEssays 2004; 26: 882-93.
8. Johansson M. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. Genomics 1999; 57: 442-45.
9. Augustin A, Spenlehauer C, Dumond H, et al. PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J Cell Sci 2003; 116: 1551-62.
10. Sallmann FR, Vodenicharov MD, Wang ZQ, et al. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks. J Biol Chem 2000; 275: 15504-11.
11. Kickhoefer VA, Siva AC, Kedersha NL, et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 1999; 146: 917-28.
12. Smith S, Giriat I, Schmitt A, et al. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484-87.
13. Chi NW, Lodish HF. Tankyrase is a Golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem 2000; 275: 38437-44.
14. Aoufouchi S, Shall S. Regulation by phosphorylation of Xenopus laevis poly(ADP-ribose) polymerase enzyme activity during oocyte maturation. Biochem J 1997; 325: 543-51.
15. Tanaka Y, Koide SS, Yoshihara K, et al. Poly (ADP-those) synthetase is phosphorylated by protein kinase C in vitro. Biochem Biophys Res Commun 1987; 148: 709-17.
16. Ariumi Y, Ueda K, Masutani M, et al. In vivo phosphorylation of poly(ADP-ribose) polymerase is independent of its activation. FEBS Lett 1998; 436: 288-92.
17. Caldini R, Barletta E, Del Rosso M, et al. FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-Kinase dependent activation of poly(ADP-ribose) polymerase. J Cell Physiol 2005; 202: 125-34.
18. Spina Purrello V, Cormaci G, Denaro L, et al. Effect of growth factors on nuclear and mitochondrial ADP-ribosylation processes during astroglial cell development and aging in culture. Mech Ageing Dev 2002; 123: 511-20.
19. Akiyama T, Takasawa S, Nata K, et al. Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(ADP-ribose)polymerase binds Reg promoter and regulates the transcription by auto-poly(ADP-ribosyl)ation. Proc Natl Acad Sci USA 2001; 98: 48-53.
20. Oliver FJ, Ménissier-de Murcia J, et al. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18: 4446-54.
21. Carrillo A, Monreal Y, Ramirez P, et al. Transcription regulation of TNF-α-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucl Acid Res 2004; 32: 757-66.
22. Dumitru CD, Ceci JD, Tsatsanis C, et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tp12/ERK-dependent pathway. Cell 2000; 103: 1071-83.
23. Homburg S, Visochek L, Moran N, et al. A fast signal-induced activation of poly(ADP-ribose) polymerase: a novel downstream target of phospholipase C. J Cell Biol 2000; 150: 293-7.
24. Gradwohl G, Mazen A, de Murcia G. Poly(ADP-ribose) polymerase forms loops with DNA. Biochem Biophys Res Commun 1987; 148: 913-19.
25. Rolli V, Ruf A, Augustin A, et al. Poly(ADP-ribose) polymerase: structure and function. In: From DNA Damage and Stress Signalling to Cell Death: Poly ADP-Ribosylation Reactions. G. de Murcia, and S. Shall, eds. New York: Oxford University Press 2000; 35-79.
26. Kun E, Kirsten E, Ordhal CP. Coenzymatic activity of randomly broken or intact double-stranded DNAs in auto and histone H1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-ribose) polymerase (PARP 1). J Biol Chem 2002; 277: 39066-69.
27. Alvarez-Gonzalez R, Althaus FR. Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents. Mutat Res 1989; 218: 67-74.
28. Griesenbeck J, Ziegler M, Tomilin N, et al. Stimulation of the catalytic activity of poly(ADP-ribosyl) transferase by transcription factor Yin Yang 1. FEBS Lett 1999; 443: 20-4.
29. Simbulan-Rosenthal CM, Rosenthal DS, Hilz H, et al. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry 1996; 35: 11622-33.
30. wafl/cip1. A dynamic exchange of partners. J Biol Chem 2003; 278: 39265-8.
31. Vispé S, Yung TM, Ritchot J, et al. A cellular defence pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc Natl Acad Sci USA 2000; 97: 9886-91.
32. Bakondi E, Bai P, Szabo EE, et al. Detection of poly(ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate. J Histochem Cytochem 2002; 50; 91-8.
33. Caldini R, Chevanne M, Magnelli L. Changes in pyridine and adenine nucleotide levels in Friend erythroleukaemia cells during growth and differentiation. J Cell Physiol 1992; 151: 172-9.
34. Bhatia M, Kirkland JB, Meckling-Gill KA Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells. Biochem J 1995; 308: 131-7.
35. Tulin A, Spradling A. Chromatin loosening by poly(ADP-ribose) polymerase (PARP) at Drosophila puff loci. Science 2003; 299: 560-62.
36. de Capoa A, Febbo FR, Giovannelli F, et al. Reduced levels of poly(ADP-ribosyl)ation result in chromatin compactation and hypermethylation as shown by cell-by-cell computer assisted quantitative analysis. FASEB J 1999; 13: 89-93.
37. d'Erme M, Zardo G, Reale A, et al. Co-operative interactions of oligonucleosomal DNA with the H1e histone variant and its poly(ADP-ribosyl)ated isoform. Biochem J 1996; 316: 475-80.
38. Rouleau M, Aubin RA, Poirier GG. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 2004; 117: 815-25.
39. De Lucia F, Mennella MR, Quesada P, et al. Poly(ADP-ribosyl)ation system in transcriptionally active rat testis chromatin fractions. J Cell Biochem 1996; 63: 334-41
40. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, et al. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 2000; 97: 11274-79.
41. Satchell MA, Zhang X, Kochanek PM, et al. A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J Neurochem 2003; 85: 697-08.
42. Cohen-Armon M, Visochek L, Katzoff A, et al. Long-term memory requires polyADP-ribosylation. Science 2004; 304: 1820-22.
43. Soldatenkov VA, Chasovskikh S, Potaman VN, et al. Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J Biol Chem 2002; 277: 665-70.
44. Meisterernst M, Stelzer G, Roeder RG. Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci USA 1997; 94: 2261-5.
45. Nirodi C, NagDas S, Gygi SP, et al. A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J Biol Chem 2001; 276: 9366-74.
46. Tulin A, Stewart D, Spradling AC. The Drosophila heterochromatic gene encoding poly(ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development. Genes Dev 2002; 16: 2108-19.
47. Butler AJ. Ordahl CP. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 1999; 19: 296-306.
48. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose) polymerase-1 as a novel coactivator of NF-kB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-53.
49. Oei SL, Griesenbeck J, Schweiger M. et al. Interaction of the transcription factor YY1 with human poly(ADP-ribosyl) transferase. Biochem Biophys Res Commun 1997; 240: 108-11.
50. Nie J, Sakamoto S, Song D, et al. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett 1998; 424: 27-32
51. Kannan P, Yu Y, Wankhade S, et al. Poly(ADP-ribose) polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucl Acid Res 1999; 27: 866-74.
52. Cervellera MN, Sala A. Poly(ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem 2000; 275: 10692-6.
53. Hassa PO, Covic M, Hasan S, et al. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 2001; 276: 45588-97.
54. Wesierska-Gadek J, Schmid G. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. Cell Mol Biol Lett. 2001; 6: 117-40.
55. Kameoka M, Ota K, Tetsuka T, et al. Evidence for regulation of NF-κB by poly(ADP-ribose) polymerase. Biochem J 2000; 346: 641-9.
56. Chang WJ, Alvarez-Gonzalez R. The sequence-specific DNA binding of NF-κB is reversibly regulated by the automodification reaction of poly(ADP-ribose) polymerase 1. J Biol Chem 2001; 276: 47664-70.
57. Oei SL, Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun 2001; 285: 27-31.
58. Dow JK, deVere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 2000; 55: 800-6.
59. Nerlov C, Rorth P, Blasi F, et al. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 1991; 6: 1583-92.
60. Andreone TL, O'Connor M, Denenberg A, et al. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003; 170: 2113-20.
61. Palazzolo M, Berthelsen J, De Cesare D, et al. Oct-1 specifically binds the UEF4 site of the human AP1-regulated urokinase enhancer. Eur J Biochem 2000; 267: 5427-37.
62. Wang W, Abbruzzese JL, Evans DB, et al. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene 1999; 18: 4554-63.
63. Le Page C, Sanceau J, Drapier JC, et al. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun 1998; 243: 451-7.
64. Ullrich O., Diestel A, Eyüpoglu YI, et al. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell Biol 2001; 3: 1035-42.
65. Chiarugi A, Moskowitz MA. Poly(ADP-ribose) polymerase-1 activity promotes NF-κB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 2003; 85: 306-17.
66. Saccani S, Pantano S, Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters J Exp Med 2001; 193: 1351-9.
67. Veres B, Radnai B, Gallyas F Jr, et al. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxy-quinazoline, in LPS-induced inflammation in mice. J Pharmacol Exp Ther 2004; 310: 247-55.
68. Wu H, Lozano G. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994; 269: 20067-74.
69. Menegazzi M, Scarpa A, Carcereri de Prati A, et al. Correlation of poly(ADP-ribose)polymerase and p53 expression levels in high-grade lymphomas. Mol Carcinog 1999; 25: 256-61.
70. Kunz C, Pebler S, Otte J, et al. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 1995; 23: 3710-7.
71. Malanga M, Pleschke J, Kleczkowska HE, et al. Poly(ADP-ribose) binds to specific domains of p53 and alter its DNA binding functions. J Biol Chem 1998; 273: 11839-43.
72. Mendoza-Alvarez H, Alvarez-Gonzalez R. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. J Biol Chem 2001; 276: 36425-30.
73. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10: 1054-72
74. Lee KC, Crowe AJ, Barton MC. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol 1999; 19: 1279-88.
75. Moroni F, Meli E, Peruginelli F, et al. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 2001; 8: 921-32.
76. Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3: 1089-95.
77. Zingarelli 13, Salzman AL, Szabo C. Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998; 83: 85-94.
78. Liaudet L, Pacher P, Mabley JG, et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372-7.
79. Soriano FG, Liaudet L, Szabo E, et al. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002; 17: 286-92.
80. Masutani M, Suzuki H, Kamada N, et al. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96: 2301-04.
81. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19: 287-98.
82. Sharp C, Warren A, Oshima T, et al. Poly(ADP-ribose) polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. Inflammation 2001; 25: 157-63.
83. Ha HC, Hester LD, Snyder SH. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci 2002; 99: 3270-5.
84. Mandir AS, Przedborski S, Jackson-Lewis V, et al. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 1999; 96: 5774-9.
85. Szabo C, Virag L, Cuzzucrea S, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
86. Martin-Oliva D, O'Valle F, Munoz-Gamez JA, et al. Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia. Oncogene 2004; 23: 5275-83.
87. Ghabreau L, Roux JP, Frappart PO, et al. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer 2004; 109: 317-21.
88. Slijepcevic P. Is there a link between telomere maintenance and radiosensitivity? Radiat Res 2004; 161: 82-6.
89. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
90. Cosi C. New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets. Expert Opin Ther Patents 2002; 12: 1047-71.
91. Kaufmann SH, Desnoyers S, Ottaviano Y, et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-85.
92. Yu SW, Wang H, Poitras MF, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-63.
93. Froelich CJ, Hanna WL, Poirier GG, et al. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem Biophys Res Commun 1996; 227: 658-65.
94. Kwan JA, Schulze CJ, Wang W, et al. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004; 18: 690-2.
95. Kraus WL, Lis JT. PARP goes transcription. Cell 2003; 113: 677-83.